1. Home
  2. Directory
  3. New Jersey
  4. Flemington
  5. Family Medicine
  6. NPI Profile
  7. Prescriptions 1083007397

DR. DEEPA SANNIDHI MD
Prescription History 1083007397
Family Medicine in Flemington, NJ

NPI Status: Active since March 11, 2015

Contact Information

2100 WESCOTT DR
FLEMINGTON, NJ
ZIP 08822
Phone: (732) 744-4331

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. DEEPA SANNIDHI MD, an active Family Medicine specialist practicing in Flemington, NJ. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 77 documented patient claims. Among these therapy options, the most frequently utilized medication is Mounjaro, which accounts for 41 claims alone.

Medication Index

M
O
T
No matching medications currently found on file.

Mounjaro

Generic Formulation: TirzepatideSpecialty: Family Practice
Provider Metrics Summary
Total Claims 41
30-Day Fills 41.0
Days Supply 1,148
NJ State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills20.4
Peer Average Days Supply584
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 141.2% higher than the standard regional baseline profile for NJ. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $45,652.89 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,113.49

State Avg Cost Per Claim

$1,224.97

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A glucose-dependent insulinotropic polypeptide (GIP) receptor and Glucose-like peptide-1 (GLP-1) receptor agonist to enhance glycemic control in adults with TYPE 2 DIABETES MELLITUS.

Therapeutic Applications

Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes.

Ozempic

Generic Formulation: SemaglutideSpecialty: Family Practice
Provider Metrics Summary
Total Claims 20
30-Day Fills 22.8
Days Supply 648
NJ State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills75.6
Peer Average Days Supply2,221
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 56.5% less volume than the regional standard for practitioners inside NJ. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $23,168.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,158.45

State Avg Cost Per Claim

$1,497.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment.

Topiramate

Generic Formulation: TopiramateSpecialty: Family Practice
Provider Metrics Summary
Total Claims 16
30-Day Fills 27.5
Days Supply 826
NJ State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills53.3
Peer Average Days Supply1,567
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 52.9% less volume than the regional standard for practitioners inside NJ. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $185.77 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.61

State Avg Cost Per Claim

$19.67

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss.

Therapeutic Applications

Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). This medication is also used to prevent migraine headaches and decrease how often you get them. Topiramate will not treat a migraine headache once it occurs. If you get a migraine headache, treat it as directed by your doctor (such as by taking pain medication, lying down in a dark room). Topiramate is known as an anticonvulsant or antiepileptic drug.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. DEEPA SANNIDHI MD provides transparency into local medical care patterns within Flemington, NJ.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Family Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.